ACHIEVE LIFE SCIENCES INC. - COMMON SHARES

Achieve Life Sciences to Announce First Quarter Financial Results and Host Conference Call and Webcast on May 9, 2024

25 Apr 2024 07:00:00 By Nasdaq GlobeNewswire

Achieve Life Sciences to Present at Life Science Innovation Northwest 2024 Conference

11 Apr 2024 07:00:00 By Nasdaq GlobeNewswire

Achieve Life Sciences Reports Financial Results for Fourth Quarter and Year-End 2023 and Provides Corporate Update

28 Mar 2024 15:01:21 By Nasdaq GlobeNewswire

Achieve Life Sciences Announces Data from Cytisinicline ORCA Program to be Presented at the 2024 Society for Research on Nicotine and Tobacco (SRNT) Annual Meeting

20 Mar 2024 07:00:00 By Nasdaq GlobeNewswire

Achieve Life Sciences to Announce Fourth Quarter and Year-End 2023 Financial Results and Host Conference Call and Webcast on March 28, 2024

14 Mar 2024 07:00:00 By Nasdaq GlobeNewswire

Achieve Life Sciences Announces Participation at Upcoming Investor Conferences

06 Mar 2024 07:00:00 By Nasdaq GlobeNewswire

Achieve Life Sciences Reaches Agreement with the FDA on Long-Term Cytisinicline Exposure Data Requirements for NDA Submission

29 Feb 2024 07:01:00 By Nasdaq GlobeNewswire

Achieve Life Sciences Announces Pricing of up to $124.2 Million Registered Direct Offering and Concurrent Private Placement

29 Feb 2024 07:00:00 By Nasdaq GlobeNewswire

Achieve Life Sciences Announces Participation at Upcoming Investor Conferences

11 Dec 2023 15:30:00 By Nasdaq GlobeNewswire

Achieve Life Sciences Reports Financial Results for Third Quarter and Provides Corporate Update

09 Nov 2023 15:00:00 By Nasdaq GlobeNewswire

Achieve Life Sciences to Announce Third Quarter 2023 Financial Results and Host Conference Call and Webcast on November 9, 2023

26 Oct 2023 07:00:00 By Nasdaq GlobeNewswire

Achieve Life Sciences Announces Participation at Upcoming Investor Conferences

03 Oct 2023 07:00:00 By Nasdaq GlobeNewswire

Achieve Life Sciences Announces Presentation of Cytisinicline E-Cigarette Cessation (ORCA-V1) Results at Society for Research on Nicotine and Tobacco Europe (SRNT-E) Annual Meeting

11 Sep 2023 07:00:00 By Nasdaq GlobeNewswire

Achieve Life Sciences Announces Participation at Upcoming Investor Conferences

07 Sep 2023 07:00:01 By Nasdaq GlobeNewswire

Achieve Life Sciences Reports Financial Results for Second Quarter 2023 and Provides Corporate Update

14 Aug 2023 15:00:00 By Nasdaq GlobeNewswire

Achieve Life Sciences to Announce Second Quarter 2023 Financial Results and Host Conference Call and Webcast

01 Aug 2023 07:00:01 By Nasdaq GlobeNewswire

Achieve Life Sciences Announces Presentation at 2023 American Society of Pharmacognosy Annual Meeting

18 Jul 2023 07:00:01 By Nasdaq GlobeNewswire

Achieve Life Sciences Announces Publication of Cytisinicline Phase 3 ORCA-2 Smoking Cessation Trial in Journal of the American Medical Association (JAMA)

11 Jul 2023 10:23:26 By Nasdaq GlobeNewswire

Achieve Life Sciences Announces Participation at Upcoming Investor Conferences

06 Jun 2023 07:00:01 By Nasdaq GlobeNewswire

Achieve Life Sciences Announces Pricing of $16.5 Million Registered Direct Offering

25 May 2023 08:00:00 By Nasdaq GlobeNewswire